Conference Proceedings

View Meeting Video

Friday, January 17, 2025  |  7:00 am - 4:00 pm

In Person
  or Virtually 
Hilton Philadelphia City Avenue,
4200 City Avenue,
Philadelphia, PA, 19131


Agenda

7:00 am

IN-PERSON: Check In, Continental Breakfast, Visit Exhibits and Experts

7:45 am

VIRTUAL: Log in to Virtual Conference

8:00 am

Welcome and Introductions

Edward A. Stadtmauer, MD  |  Activity Director

Robert H. Vonderheide, MD, DPhil  |  Director, Abramson Cancer Center

8:10 am

Keynote Address: T Cell-Based Therapeutic Alternatives for B-Cell Lymphomas

Stephen J. Schuster, MD  |  Activity Co-Director

Q&A Discussion

MODERATOR: Edward A. Stadtmauer, MD  |  Activity Director

NEW THERAPIES AND CURRENT PATIENT MANAGEMENT OF LYMPHOMAS

MODERATOR: Sunita D. Nasta, MD, FACP  

8:40 am

Sequencing New Therapies in Follicular Lymphoma

8:55 am

Advances in CLL/SLL

9:10 am

Updates in Management of Hodgkin Lymphoma

Jakub Svoboda, MD  |  Activity Co-Director

9:25 am

Therapeutic Advances in T-Cell Lymphomas

9:40 am

Novel Approaches to Managing Large B-Cell Lymphomas

9:55 am

Evolving Treatment Strategies in Mantle Cell Lymphoma

10:50 am

Break and Visit Exhibits

UPDATE IN BLOOD, MARROW TRANSPLANTATION AND CELLULAR THERAPY

MODERATOR: Nasheed M. Hossain, MD  |  Activity Co-Director

11:05 am

Current and Future Immunotherapies of Acute Leukemias

11:20 am

Cell Therapy Approaches for Autoimmune Disease

Nasheed M. Hossain, MD  |  Activity Co-Director

11:35 am

Progress in GVHD Therapies

11:50 am

MODERATORS: Nasheed M. Hossain, MD  |  Activity Co-Director

PANEL:

Nicholas K. Brown, PhD, F(ACHI)  | Pathology and Laboratory Medicine
Pashna N. Munshi, MD  
Linda M. Perry, MS, PA-C  
John P. Plastaras, MD, PhD  |  Radiation Oncology

12:10 pm

Lunch Break and Visit Exhibits

UPDATE ON PATIENT CARE TREATMENT STRATEGIES IN LEUKEMIA

Moderator: Catherine E. Lai, MD, MPH  |  Activity Co-Director

  1:10 pm

Emerging Treatment Options for AML

1:25 pm

MDS Bone Marrow Failure Syndromes

1:40 pm

Update in Myeloproliferative Neoplasms

1:55 pm

Equal Access to Transplant: Mismatched Donors for Blood Cancers

2:10 pm

Panel Discussion

CONTROVERSIES AND UPDATE FOR PATIENT CARE IN MULTIPLE MYELOMA

Moderator: Edward A. Stadtmauer, MD  |  Activity Director

2:35 pm

Smoldering Myeloma and Amyloidosis

2:50 pm

Initial Therapy for Multiple Myeloma Including Transplant

3:05 pm

Role of Immunotherapy for Myeloma

3:20 pm

Investigational Therapies for Relapsed Myeloma

3:35 pm

Panel Discussion

4:00 pm

Adjourn